查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
生物数据可视化市场规模、份额和趋势分析报告：按技术（显微镜、测序）、应用（系统生物学）、平台、最终用途、地区、细分市场预测，2022-2030 年
市场调查报告书
商品编码
1147524

生物数据可视化市场规模、份额和趋势分析报告：按技术（显微镜、测序）、应用（系统生物学）、平台、最终用途、地区、细分市场预测，2022-2030 年

Biological Data Visualization Market Size, Share & Trends Analysis Report By Technique (Microscopy, Sequencing), By Application (Systems Biology), By Platform, By End-use, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

生物数据可视化市场增长及趋势

根据 Grand View Research, Inc. 的最新报告，到 2030 年，全球生物数据可视化市场预计将达到 13 亿美元。从 2022 年到 2030 年，该市场预计将以 12.0% 的复合年增长率增长。基因组学和蛋白□□质组学研究的兴起是主要的市场驱动力之一。市场参与者正专注于新产品发布、併购和技术合作等战略举措，以增加他们在生物数据可视化市场的份额。例如，2021 年 8 月，DNAnexus, Inc. 宣布其生物医学信息学平台标准超出了美国政府最近一项行政命令中规定的在线安全政策目标。这让NGS终端用户对产品更有信心，并帮助他们以高安全性管理大规模生物医学信息。

生命科学研究人员和从业人员依靠可视化技术来解决理解和解释生物信息方面的各种挑战。原始计算和图形处理能力的快速发展促进了生物信息在多功能桌面平台上的可视化。此外，越来越多地采用下一代测序 (NGS) 技术和其他生物数据采集方法，生成新型数据集，增加了研究人员和科学家对可视化工具的需求。

例如，西班牙已成为 NGS 数据分析极具吸引力和竞争性的市场。 2020 年 9 月，西班牙政府拨款 2950 万美元用于精准医学和基因组医学以及数据科学。该投资旨在利用科学知识作为增强该地区卫生系统能力的工具，并通过促进创新使其在经济上具有竞争力。两年（2020-22）的拨款总额为 8933 万美元。投资类别包括基因组医学、大数据健康、预测医学、先进和个性化医学以及精准医学培训。

COVID-19 大流行增加了序列信息分析平台的使用，这些平台在病毒检测和跟踪方面发挥着重要作用，支持生物数据可视化市场的增长。部署了各种序列监控平台和解决方案，以有效诊断感染。此外，主要利益相关者正在采取一系列战略举措，包括合作和联合研究许可，以抗击这种疾病。例如，2021 年 2 月，加拿大政府投资 5300 万美元实施多层次方法诊断 COVID-19。加拿大政府计划利用基因组测序技术来达到预期的效果。

分析和商业智能解决方案的技术进步、大数据的快速增长以及对更快决策制定的日益增长的需求是推动生物信息学领域对可视化工具需求的其他一些因素。大量的高维生物信息需要机器学习和先进的数据可视化方法才能被人类专家轻鬆理解。

另一方面，生物数据可视化市场具有分散性，有大量公司，从大型全球参与者到较小的本地或区域参与者。市场上的主要供应商包括 QIAGEN、Thermo Fisher Scientific Inc.、Agilent Technologies, Inc.、Becton-Dickinson and Company 和 3M。

生物数据可视化市场报告亮点

从技术来看，测序预计将在 2021 年占据很大份额。测序产生的大量信息需要数据管理解决方案和平台，导致对生物研究工具和算法的高需求。

按应用来看，基因组分析领域有望在 2021 年占据生物数据可视化市场的很大份额。某些因素，例如增加对新平台开发的投资、积极采用分析解决方案以及技术创新，正在推动该应用中新产品的推出。

按平台划分，Mac OS 有望在生物数据可视化市场中增长最快。该操作系统设计为用户友好且简单，并具有许多安全功能来保护您的信息。

从最终用户来看，学术研究领域预计将在 2021 年占据大部分市场份额。这是由于在研究和数据可视化工具的实施过程中使用了下一代测序 (NGS) 和 X 射线晶体学技术。因此，在这些设施中越来越多地实施此类技术将推动对可视化工具的需求，以准确观察生物学研究中的研究结果。

由于主要公司在该地区的存在以及与基因组学和系统生物学相关的大量研究项目，北美将在 2021 年成为生物数据可视化的区域市场。

内容

第 1 章研究方法论

  • 按国家/地区划分的市场：基本估计
  • 全球市场：CAGR 计算
  • 按地区计算细分市场份额
  • 调查范围和假设
  • 数据源列表
    • 来自主要访谈的数据（按来源）
    • 按地区划分的首次访谈数据

第 2 章执行摘要

  • 市场概况

第 3 章生物数据可视化市场变量、趋势和范围

  • 市场系列展望
  • 市场动态
    • 市场促进因素分析
      • 生物数据的快速增长
      • 将人工智能融入生物数据分析
      • 对更快决策的需求不断增加
    • 市场抑制因素分析
      • 数据可视化带来的用户界面挑战
      • 数据管理计算缺乏一致性
  • 2021 年应用程序渗透率和增长前景图
  • 生物识别数据可视化市场 - SWOT 分析，按因素（政治与法律、经济与技术）
  • 行业分析 - 搬运工
  • 对主要交易和战略联盟的分析
    • 产品开发
    • 併购
    • 合作与伙伴关係
    • 协议
  • 市场进入策略
  • COVID-19 影响分析

第 4 章生物数据可视化市场分类：技术估计和趋势分析

  • 市场：技术波动分析，2021 年和 2030 年
  • 显微镜
  • 磁共振成像
  • 测序
  • X射线晶体学
  • 其他

第 5 章生物数据可视化市场分类：应用估计和趋势分析

  • 生物数据可视化市场：应用变化分析，2021 年和 2030 年
  • 成像细胞和生物体
  • 结构生物学和分子建模
  • 基因组分析
  • 对齐、系统发育和进化
  • 系统生物学

第 6 章生物数据可视化市场分类：平台估计和趋势分析

  • 生物数据可视化市场：平台波动分析，2021 年和 2030 年
  • WINDOWS
  • 苹果操作系统
  • Linux
  • 其他

第 7 章生物数据可视化市场分类：最终用途估计和趋势分析

  • 市场：最终用途变化分析，2021 年和 2030 年
  • 学术研究
  • 医院和诊所
  • 製药和生物技术公司
  • 其他

第 8 章生物数据可视化市场分类：按技术、应用、平台和最终用途的区域估计和趋势分析

  • 生物数据可视化市场：区域差异分析，2021 年和 2030 年
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳大利亚
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国

第 9 章竞争格局

  • 战略框架
  • 市场参与分类
  • 主要市场进入者的近期趋势和影响分析
  • 上市公司
    • 绘製知名行业参与者的渗透率和增长前景，2021 年
  • 私人公司
    • 主要初创公司名单
  • 公司简介
    • 3M
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Thermo Fisher Scientific, Inc.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Tableau Software, LLC
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Agilent Technologies Inc.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • QIAGEN
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • ZEISS International
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Oxford Instruments
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Olympus Corporation
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Clarivate
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • General Electric Company
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
Product Code: GVR-4-68038-504-5

Biological Data Visualization Market Growth & Trends:

The global biological data visualization market size is expected to reach USD 1.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.0% from 2022 to 2030. The growing research in genomics and proteomics is one of the major market drivers. Major companies in the market are focusing on strategic initiatives such as new product launches, mergers and acquisitions, and technological collaborations, to increase their share in the biological data visualization market. For instance, in August 2021, DNAnexus, Inc. announced that the standards of the biomedical informatics platform outperformed the online security policy objectives outlined in the U.S. Government's recent executive order. This helped build confidence in the product among NGS end-users and assisted in managing large biomedical information with high security.

The life-science researchers and practitioners rely on visualization techniques for solving a wide range of challenges in understanding and interpreting biological information. Rapid advancements in raw computing power and graphics processing power make visualization of biological information easier on commodity desktop platforms. Besides, the increase in the adoption Of Next-Generation Sequencing (NGS) techniques and other biological data-acquisition approaches, which generate new types and sets of data, necessitates the demand for visualization tools among researchers and scientists.

For instance, Spain has become an attractive and competitive market for NGS data analysis. In September 2020, the Government of Spain allocated USD 29.5 million for precision and genomic medicine, and data science. This investment aims to enhance the capacity of the regional health system and use scientific knowledge as a tool to embrace economic competitiveness by contributing to innovation. The total funds allocated for 2 years (2020-22) is USD 89.33 million. The segment of investment includes genomic medicine, big data health, predictive medicine, advanced and personalized therapy, and precision medicine training.

The COVID-19 pandemic resulted in increased usage of sequencing information analysis platform plays a crucial role in the detection and tracing of the virus and support the growth of the biological data visualization market. Various sequencing surveillance platforms and solutions are being deployed for the effective diagnosis of infection. Furthermore, key stakeholders are undertaking various strategic initiatives, such as collaborations and licensing for collaborative efforts, to combat the disease. For instance, in February 2021, the Canadian government invested USD 53 million to implement a multilayered approach to the diagnosis of COVID-19. The Canadian government will utilize genome sequencing and analysis technologies to achieve desired outcomes.

Technological advancements in analytical and business intelligence solutions coupled with rapid growth in big data and the rise in the need for faster decision-making are a few other drivers boosting the demand for visualization tools in the bioinformatics field. The sheer amount of high-dimensional biological information needs machine learning and advanced data visualization approaches so that it can be easily understandable by human experts.

On the other hand, the biological data visualization market is fragmented in nature with a substantial number of companies ranging from large global players to small mid-sized local or regional players. Some of the public key vendors operating in the market include QIAGEN, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Becton-Dickinson and Company, and 3M.

Biological Data Visualization Market Report Highlights:

  • By technique, sequencing is estimated to have a major market share in 2021. The large amount of information generated through sequencing needs data management solutions and platforms, resulting in high demand for tools & algorithms for biological research.
  • By application, the genomic analysis segment is anticipated to have a significant share of the biological data visualization market in 2021. Certain factors such as increasing investment for the development of new platforms, a positive approach toward the adoption of analytical solutions, and technological innovations are leveraging new product launches in this application.
  • By platform, Mac OS is anticipated to be the fastest-growing segment in the biological data visualization market. Since the operating system has a user-friendly and simple design with better in-built security features for protecting information.
  • By end-user, the academic research segment is estimated to have a majority of the market share in 2021. This is attributed to the use of next-generation sequencing (NGS), and X-ray crystallography methods during their research to implement data visualization tools. Thus, an increase in the implementation of such techniques in these facilities drives the demand for visualization tools to precisely observe their research findings in biological research.
  • North America is considered to be a dominating regional market for biological data visualization in 2021 owing to the local presence of key players in the region and a significant number of research projects related to genomic analysis and systems biology.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Country Wise Market: Base Estimates
  • 1.2 Global Market: CAGR Calculation
  • 1.3 Region-Based Segment Share Calculation
  • 1.4 Research Scope & Assumptions
  • 1.5 List of Data Sources
    • 1.5.1 Data for primary interviews, by sources
    • 1.5.2 Data for primary interviews, by region

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Biological Data Visualization Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market driver analysis
      • 3.2.1.1 Rapid growth of biological data
      • 3.2.1.2 Incorporation of artificial intelligence in analysis of biological data
      • 3.2.1.3 Growing demand for faster decision making
    • 3.2.2 Market restraint analysis
      • 3.2.2.1 User- interface challenges pertaining to data visualization
      • 3.2.2.2 Lack of computational consistency for data management
  • 3.3 Penetration & Growth Prospect Mapping for Application, 2021
  • 3.4 Biological Data Visualization Market-SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • 3.5 Industry Analysis - Porter's
  • 3.6 Major Deals & Strategic Alliances Analysis
    • 3.6.1 Product developments
    • 3.6.2 Merger & acquisition
    • 3.6.3 Collaboration & partnership
    • 3.6.4 Agreement
  • 3.7 Market Entry Strategies
  • 3.8 COVID-19 Impact Analysis

Chapter 4 Biological Data Visualization Market Categorization: Technique Estimates & Trend Analysis

  • 4.1 Market: Technique Movement Analysis, 2021 & 2030
  • 4.2 Microscopy
    • 4.2.1 Microscopy Market, 2018 - 2030 (USD Million)
  • 4.3 Magnetic Resonance Imaging
    • 4.3.1 MRI Market, 2018 - 2030 (USD Million)
  • 4.4 Sequencing
    • 4.4.1 Sequencing Market, 2018 - 2030 (USD Million)
  • 4.5 X-ray Crystallography
    • 4.5.1 X-ray crystallography Market, 2018 - 2030 (USD Million)
  • 4.6 Others
    • 4.6.1 Others Market, 2018 - 2030 (USD Million)

Chapter 5 Biological Data Visualization Market Categorization: Application Estimates & Trend Analysis

  • 5.1 Biological Data Visualization Market: Application Movement Analysis, 2021 & 2030
  • 5.2 Cell and Organism Imaging
    • 5.2.1 Cell and Organism Imaging Market, 2018 - 2030 (USD Million)
  • 5.3 Structural Biology and Molecular Modeling
    • 5.3.1 Structural Biology and Molecular Modeling Market, 2018 - 2030 (USD Million)
  • 5.4 Genomic Analysis
    • 5.4.1 Genomic Analysis Market, 2018 - 2030 (USD Million)
  • 5.5 Alignments, Phylogeny, and Evolution
    • 5.5.1 Alignments, Phylogeny, And Evolution Market, 2018 - 2030 (USD Million)
  • 5.6 Systems Biology
    • 5.6.1 Systems Biology Market, 2018 - 2030 (USD Million)

Chapter 6 Biological Data Visualization Market Categorization: Platform Estimates & Trend Analysis

  • 6.1 Biological Data Visualization Market: Platform Movement Analysis, 2021 & 2030
  • 6.2 Windows
    • 6.2.1 Windows Market, 2018 - 2030 (USD Million)
  • 6.3 MAC OS
    • 6.3.1 MAC OS Market, 2018 - 2030 (USD Million)
  • 6.4 Linux
    • 6.4.1 Linux Market, 2018 - 2030 (USD Million)
  • 6.5 Others
    • 6.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 7 Biological Data Visualization Market Categorization: End-use Estimates & Trend Analysis

  • 7.1 Market: End-use Movement Analysis, 2021 & 2030
  • 7.2 Academic Research
    • 7.2.1 Academic Research Market, 2018 - 2030 (USD Million)
  • 7.3 Hospitals & Clinics
    • 7.3.1 Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • 7.4 Pharmaceutical & Biotechnology Companies
    • 7.4.1 Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 7.5 Others
    • 7.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 8 Biological Data Visualization Market Categorization: Regional Estimates & Trend Analysis, by Technique, Application, Platform, & End-use

  • 8.1 Biological Data Visualization Market: Regional Movement Analysis, 2021 & 2030
  • 8.2 North America
    • 8.2.1 North America biological data visualization market, by technique, 2018 - 2030 (USD Million)
    • 8.2.2 North America biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.2.3 North America biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.2.4 North America biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.2.5 U.S.
      • 8.2.5.1 U.S. biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.2.5.2 U.S. biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.2.5.3 U.S. biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.2.5.4 U.S. biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.2.6 Canada
      • 8.2.6.1 Canada biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.2.6.2 Canada biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.2.6.3 Canada biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.2.6.4 Canada biological data visualization market, by end-use, 2018 - 2030 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe biological data visualization market, by technique, 2018 - 2030 (USD Million)
    • 8.3.2 Europe biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.3.3 Europe biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.3.4 Europe biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.3.5 Germany
      • 8.3.5.1 Germany biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.3.5.2 Germany biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.3.5.3 Germany biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.3.5.4 Germany biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.3.6 U.K.
      • 8.3.6.1 U.K. biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.3.6.2 U.K. biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.3.6.3 U.K. biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.3.6.4 U.K. biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.3.7 France
      • 8.3.7.1 France biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.3.7.2 France biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.3.7.3 France biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.3.7.4 France biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.3.8 Italy
      • 8.3.8.1 Italy biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.3.8.2 Italy biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.3.8.3 Italy biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.3.8.4 Italy biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.3.9 Spain
      • 8.3.9.1 Spain biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.3.9.2 Spain biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.3.9.3 Spain biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.3.9.4 Spain biological data visualization market, by end-use, 2018 - 2030 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific biological data visualization market, 2018 - 2030 (USD Million)
    • 8.4.2 Asia Pacific biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.4.3 Asia Pacific biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.4.4 Asia Pacific biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.4.5 Japan
      • 8.4.5.1 Japan biological data visualization market, 2018 - 2030 (USD Million)
      • 8.4.5.2 Japan biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.4.5.3 Japan biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.4.5.4 Japan biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.4.6 China
      • 8.4.6.1 China biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.4.6.2 China biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.4.6.3 China biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.4.6.4 China biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.4.7 India
      • 8.4.7.1 India biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.4.7.2 India biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.4.7.3 India biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.4.7.4 India biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.4.8 South Korea
      • 8.4.8.1 South Korea biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.4.8.2 South Korea biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.4.8.3 South Korea biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.4.8.4 South Korea biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.4.9 Australia
      • 8.4.9.1 Australia biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.4.9.2 Australia biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.4.9.3 Australia biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.4.9.4 Australia biological data visualization market, by end-use, 2018 - 2030 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America biological data visualization market, by technique, 2018 - 2030 (USD Million)
    • 8.5.2 Latin America biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.5.3 Latin America biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.5.4 Latin America biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.5.5 Brazil
      • 8.5.5.1 Brazil biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.5.5.2 Brazil biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.5.5.3 Brazil biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.5.5.4 Brazil biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.5.6 Mexico
      • 8.5.6.1 Mexico biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.5.6.2 Mexico biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.5.6.3 Mexico biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.5.6.4 Mexico biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.5.7 Argentina
      • 8.5.7.1 Argentina biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.5.7.2 Argentina biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.5.7.3 Argentina biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.5.7.4 Argentina biological data visualization market, by end-use, 2018 - 2030 (USD Million)
  • 8.6 Middle East and Africa (MEA)
    • 8.6.1 MEA biological data visualization market, by technique, 2018 - 2030 (USD Million)
    • 8.6.2 MEA biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.6.3 MEA biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.6.4 MEA biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.6.5 South Africa
      • 8.6.5.1 South Africa biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.6.5.2 South Africa biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.6.5.3 South Africa biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.6.5.4 South Africa biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.6.6 Saudi Arabia
      • 8.6.6.1 Saudi Arabia biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.6.6.2 Saudi Arabia biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.6.6.3 Saudi Arabia biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.6.6.4 Saudi Arabia biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.6.7 UAE
      • 8.6.7.1 UAE biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.6.7.2 UAE biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.6.7.3 UAE biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.6.7.4 UAE biological data visualization market, by end-use, 2018 - 2030 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Strategy Framework
  • 9.2 Market Participation Categorization
  • 9.3 Recent Developments & Impact Analysis, by Key Market Participants
  • 9.4 Public Companies
    • 9.4.1 Penetration & growth prospect mapping for prominent industry players, 2021
  • 9.5 Private Companies
    • 9.5.1 List of key emerging companies
  • 9.6 Company Profiles
    • 9.6.1 3M
      • 9.6.1.1 Company overview
      • 9.6.1.2 Financial performance
      • 9.6.1.3 Product benchmarking
      • 9.6.1.4 Strategic initiatives
    • 9.6.2 Thermo Fisher Scientific, Inc.
      • 9.6.2.1 Company overview
      • 9.6.2.2 Financial performance
      • 9.6.2.3 Product benchmarking
      • 9.6.2.4 Strategic initiatives
    • 9.6.3 Tableau Software, LLC
      • 9.6.3.1 Company overview
      • 9.6.3.2 Financial performance
      • 9.6.3.3 Product benchmarking
      • 9.6.3.4 Strategic initiatives
    • 9.6.4 Agilent Technologies Inc.
      • 9.6.4.1 Company overview
      • 9.6.4.2 Financial performance
      • 9.6.4.3 Product benchmarking
      • 9.6.4.4 Strategic initiatives
    • 9.6.5 QIAGEN
      • 9.6.5.1 Company overview
      • 9.6.5.2 Financial performance
      • 9.6.5.3 Product benchmarking
      • 9.6.5.4 Strategic initiatives
    • 9.6.6 ZEISS International
      • 9.6.6.1 Company overview
      • 9.6.6.2 Financial performance
      • 9.6.6.3 Product benchmarking
      • 9.6.6.4 Strategic initiatives
    • 9.6.7 Oxford Instruments
      • 9.6.7.1 Company overview
      • 9.6.7.2 Financial performance
      • 9.6.7.3 Product benchmarking
      • 9.6.7.4 Strategic initiatives
    • 9.6.8 Olympus Corporation
      • 9.6.8.1 Company overview
      • 9.6.8.2 Financial performance
      • 9.6.8.3 Product benchmarking
      • 9.6.8.4 Strategic initiatives
    • 9.6.9 Clarivate
      • 9.6.9.1 Company overview
      • 9.6.9.2 Financial performance
      • 9.6.9.3 Product benchmarking
      • 9.6.9.4 Strategic initiatives
    • 9.6.10 General Electric Company
      • 9.6.10.1 Company overview
      • 9.6.10.2 Financial performance
      • 9.6.10.3 Product benchmarking
      • 9.6.10.4 Strategic initiatives

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Global Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 4 Global Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 5 Global Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 6 Global Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 7 Global Biological Data Visualization, by Region, 2018 - 2030 (USD Million)
  • TABLE 8 North America Biological Data Visualization, by Country, 2018 - 2030 (USD Million)
  • TABLE 9 North America Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 10 North America Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 11 North America Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 12 North America Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 13 U.S. Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 14 U.S. Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 15 U.S. Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 16 U.S. Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 17 Canada Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 18 Canada Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 19 Canada Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 20 Canada Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 21 Europe Biological Data Visualization, by Country, 2018 - 2030 (USD Million)
  • TABLE 22 Europe Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 23 Europe Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 24 Europe Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 25 Europe Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 26 Germany Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 27 Germany Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 28 Germany Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 29 Germany Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 30 U.K. Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 31 U.K. Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 32 U.K. Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 33 U.K. Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 34 France Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 35 France Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 36 France Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 37 France Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 38 Italy Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 39 Italy Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 40 Italy Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 41 Italy Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 42 Spain Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 43 Spain Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 44 Spain Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 45 Spain Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 46 Asia Pacific Biological Data Visualization, by Country, 2018 - 2030 (USD Million)
  • TABLE 47 Asia Pacific Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 48 Asia Pacific Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 49 Asia Pacific Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 50 Asia Pacific Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 51 China Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 52 China Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 53 China Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 54 China Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 55 Japan Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 56 Japan Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 57 Japan Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 58 Japan Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 59 India Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 60 India Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 61 India Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 62 India Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 63 South Korea Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 64 South Korea Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 65 South Korea Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 66 South Korea Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 67 Australia Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 68 Australia Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 69 Australia Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 70 Australia Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 71 Latin America Biological Data Visualization, by Country, 2018 - 2030 (USD Million)
  • TABLE 72 Latin America Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 73 Latin America Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 74 Latin America Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 75 Latin America Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 76 Brazil Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 77 Brazil Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 78 Brazil Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 79 Brazil Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 80 Mexico Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 81 Mexico Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 82 Mexico Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 83 Mexico Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 84 Argentina Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 85 Argentina Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 86 Argentina Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 87 Argentina Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 88 Middle East & Africa Biological Data Visualization, by Country, 2018 - 2030 (USD Million)
  • TABLE 89 Middle East & Africa Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 90 Middle East & Africa Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 91 Middle East & Africa Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 92 Middle East & Africa Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 93 South Africa Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 94 South Africa Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 95 South Africa Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 96 South Africa Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 97 Saudi Arabia Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 98 Saudi Arabia Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 99 Saudi Arabia Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 100 Saudi Arabia Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 101 UAE Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 102 UAE Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 103 UAE Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 104 UAE Biological Data Visualization, End-use, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information Procurement
  • FIG. 3 Primary Research Pattern
  • FIG. 4 Market Research Approaches
  • FIG. 5 Value Chain-Based Sizing & Forecasting
  • FIG. 6 Market Formulation & Validation
  • FIG. 7 Biological Data Visualization, Market Segmentation
  • FIG. 8 Market Snapshot, 2021
  • FIG. 9 Market Trends & Outlook
  • FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • FIG. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • FIG. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • FIG. 14 Porter's Five Forces Analysis
  • FIG. 15 Market Penetration Vs Growth Prospect Mapping, 2021
  • FIG. 16 Global Biological Data Visualization: Technique Movement Analysis
  • FIG. 17 Global Biological Data Visualization, for Microscopy, 2018 - 2030 (USD Million)
  • FIG. 18 Global Biological Data Visualization, for MAGNETIC resonance imaging, 2018 - 2030 (USD Million)
  • FIG. 19 Global Biological Data Visualization, for Sequencing, 2018 - 2030 (USD Million)
  • FIG. 20 Global Biological Data Visualization, for X-ray Crystallography, 2018 - 2030 (USD Million)
  • FIG. 21 Global Biological Data Visualization, for Others, 2018 - 2030 (USD Million)
  • FIG. 22 Global Biological Data Visualization: Application Movement Analysis
  • FIG. 23 Global Biological Data Visualization, for Cell and Organism Imaging, 2018 - 2030 (USD Million)
  • FIG. 24 Global Biological Data Visualization, for Structural biology and Molecular Modeling, 2018 - 2030 (USD Million)
  • FIG. 25 Global Biological Data Visualization, for Genomic Analysis, 2018 - 2030 (USD Million)
  • FIG. 26 Global Biological Data Visualization, for Alignments, phylogeny, and Evolution, 2018 - 2030 (USD Million)
  • FIG. 27 Global Biological Data Visualization, for Systems Biology, 2018 - 2030 (USD Million)
  • FIG. 28 Global Biological Data Visualization: Platform Movement Analysis
  • FIG. 29 Global Biological Data Visualization, for Windows, 2018 - 2030 (USD Million)
  • FIG. 30 Global Biological Data Visualization, for Mac OS, 2018 - 2030 (USD Million)
  • FIG. 31 Global Biological Data Visualization, for Linux, 2018 - 2030 (USD Million)
  • FIG. 32 Global Biological Data Visualization, for Others, 2018 - 2030 (USD Million)
  • FIG. 33 Global Biological Data Visualization: End-Use Movement Analysis
  • FIG. 34 Global Biological Data Visualization, for Academic Institutes & Research Centers, 2018 - 2030 (USD Million)
  • FIG. 35 Global Biological Data Visualization, for Pharmaceutical & Biotechnology Companies, 2018 - 2030 (USD Million)
  • FIG. 36 Global Biological Data Visualization, for Others, 2018 - 2030 (USD Million)
  • FIG. 37 Regional Marketplace: Key Takeaways
  • FIG. 38 Regional Outlook, 2021 & 2030
  • FIG. 39 Global Biological Data Visualization: Region Movement Analysis
  • FIG. 40 North America Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 41 U.S. Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 42 Canada Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 43 Europe Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 44 Germany Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 45 U.K. Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 46 France Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 47 Italy Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 48 Spain Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 49 Asia Pacific Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 50 Japan Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 51 China Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 52 India Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 53 Australia Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 54 South Korea Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 55 Latin America Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 56 Brazil Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 57 Mexico Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 58 Argentina Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 59 Middle East and Africa Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 60 South Africa Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 61 Saudi Arabia Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 62 UAE Biological Data Visualization, 2018 - 2030 (USD Million)